 Male and female patients  Age >18-70 years at the time of informed consent signature  having a recent positive direct test for Sars-CoV-2  having mild or moderate Covid-19 symptoms (not needing more than 4 l oxygen per minute to reach a saturation of 95%)  Body Mass Index (BMI) between 18.0 and 30 kg/m², inclusive at screening.  Subject must have signed the informed consent form prior to the first study-related procedure indicating they understand the purpose of and procedures required for the study and are willing to participate in it (including willing to be hospitalized during the medication period of the study).

 Male and female patients  Age >18-70 years at the time of informed consent signature  having a recent positive direct test for Sars-CoV-2  having mild or moderate Covid-19 symptoms (not needing more than 4 l oxygen per minute to reach a saturation of 95%)  Body Mass Index (BMI) between 18.0 and 30 kg/m², inclusive at screening.  Subject must have signed the informed consent form prior to the first study-related procedure indicating they understand the purpose of and procedures required for the study and are willing to participate in it (including willing to be hospitalized during the medication period of the study).